National Institutes of Health funding will help physicians and researchers improve hydroxyurea treatment management for sickle cell patients in Memphis.
St. Jude and Methodist Healthcare sign agreement to advance center for adult sickle cell disease in Memphis
The newly expanded Methodist Comprehensive Sickle Cell Center will strengthen research into sickle cell disease and serve the growing needs of patients in the Memphis area.
Proteinpaint database collaboration will make it easier for any scientist to explore cancer genome data.
St. Jude researchers provide experimental evidence to demonstrate how stem cells contribute to cancer risk.
A new gene editing approach eases the effects of sickle cell disease in blood cells isolated from patients.
Molecular "master assassin" identified that recognizes flu-infected cells and triggers cell death, raises hope for drugs to prevent flu complications.
Variations in a porphyrin transport protein may affect symptom severity in patients with porphyria, a rare disorder of skin, liver and nervous system.
The addition of adjuvants to influenza vaccines offers no protection from severe flu infections in study looking at obesity.
Influenza surveillance in migratory waterfowl suggests that highly pathogenic avian flu viruses do not persist in wild aquatic birds
Experts have developed a list of preferred terms to promote standardize reporting of pharmacogenetic test results in patients’ health records
Explore more research news
More Research News
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Twitter
Connect with @stjuderesearch to keep up with our latest science and medical discoveries.
Browse all scientific publications by St. Jude investigators in 2015.